A Zebrafish embryo at an early stage of development (Jeffrey Farrell, Schier Lab/Harvard University)
Investment Thesis
10x Genomics (TXG) is leading the cell revolution hailed by the prestigious Science Magazine as the “breakthrough of the year“ in 2018. The market is in the early stage and the company's success is only beginning. Investors have an opportunity to capitalize on a novel and expanding market.
10x Genomics' revenue growth is impressive, reflecting the scientific community's acceptance of the company's novel technology. The number of research papers using the company’s products in its